Published in J Immunol on December 01, 1994
Constitutive class I-restricted exogenous presentation of self antigens in vivo. J Exp Med (1996) 5.21
Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns. Nat Rev Immunol (2010) 4.06
Role of heat shock proteins in protection from and pathogenesis of infectious diseases. Clin Microbiol Rev (1999) 2.69
Major histocompatibility complex class I presentation of peptides derived from soluble exogenous antigen by a subset of cells engaged in phagocytosis. J Exp Med (1995) 2.24
Gene vaccination with naked plasmid DNA: mechanism of CTL priming. J Exp Med (1996) 2.18
Enhanced and prolonged cross-presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles. Immunology (2006) 1.92
Interleukin-12 production by human monocytes infected with Mycobacterium tuberculosis: role of phagocytosis. Infect Immun (1996) 1.77
Major histocompatibility class I presentation of soluble antigen facilitated by Mycobacterium tuberculosis infection. Proc Natl Acad Sci U S A (1996) 1.76
Cross-presentation of cell-associated antigens by CD8alpha+ dendritic cells is attributable to their ability to internalize dead cells. Immunology (2002) 1.72
Chloroquine enhances human CD8+ T cell responses against soluble antigens in vivo. J Exp Med (2005) 1.50
In vivo induction of a high-avidity, high-frequency cytotoxic T-lymphocyte response is associated with antiviral protective immunity. J Virol (2000) 1.45
Murine cytotoxic T lymphocytes induced following Chlamydia trachomatis intraperitoneal or genital tract infection respond to cells infected with multiple serovars. Infect Immun (1995) 1.20
Generation of CD8(+) T-cell responses to Mycobacterium bovis and mycobacterial antigen in experimental bovine tuberculosis. Infect Immun (1999) 1.12
Induction of cytotoxic T-cell responses against culture filtrate antigens in Mycobacterium bovis bacillus Calmette-Guérin-infected mice. Infect Immun (1997) 1.11
Synthetic Nanoparticles for Vaccines and Immunotherapy. Chem Rev (2015) 1.10
DNA vaccines against human immunodeficiency virus type 1 in the past decade. Clin Microbiol Rev (2004) 1.06
Intracellular delivery of a cytolytic T-lymphocyte epitope peptide by pertussis toxin to major histocompatibility complex class I without involvement of the cytosolic class I antigen processing pathway. Infect Immun (1999) 1.04
Lesions of primary and secondary syphilis contain activated cytolytic T cells. Infect Immun (1996) 1.03
Transporters associated with antigen processing (TAP)-independent presentation of soluble insulin to alpha/beta T cells by the class Ib gene product, Qa-1(b). J Exp Med (1998) 1.02
Intracellular delivery of a protein antigen with an endosomal-releasing polymer enhances CD8 T-cell production and prophylactic vaccine efficacy. Bioconjug Chem (2010) 1.00
Liposomes containing lipid A serve as an adjuvant for induction of antibody and cytotoxic T-cell responses against RTS,S malaria antigen. Infect Immun (1998) 0.98
Presentation of phagocytosed antigens by MHC class I and II. Traffic (2012) 0.98
Technical advance: Caspase-1 activation and IL-1β release correlate with the degree of lysosome damage, as illustrated by a novel imaging method to quantify phagolysosome damage. J Leukoc Biol (2010) 0.96
T-cell activation by antigen-loaded pH-sensitive hydrogel particles in vivo: the effect of particle size. Bioconjug Chem (2009) 0.94
Processing of Mycobacterium tuberculosis bacilli by human monocytes for CD4+ alphabeta and gammadelta T cells: role of particulate antigen. Infect Immun (1998) 0.93
Antigen processing for MHC class I restricted presentation of exogenous influenza A virus nucleoprotein by B-lymphoblastoid cells. Clin Exp Immunol (2001) 0.93
Particle platforms for cancer immunotherapy. Int J Nanomedicine (2013) 0.93
The ability of heat-killed Mycobacterium vaccae to stimulate a cytotoxic T-cell response to an unrelated protein is associated with a 65 kilodalton heat-shock protein. Immunology (2001) 0.92
Efficient scavenger receptor-mediated uptake and cross-presentation of negatively charged soluble antigens by dendritic cells. Immunology (2004) 0.91
Cytotoxic T-lymphocyte epitopes fused to anthrax toxin induce protective antiviral immunity. Infect Immun (1999) 0.90
Formulation and Characterization of Antigen-loaded PLGA Nanoparticles for Efficient Cross-priming of the Antigen. Immune Netw (2011) 0.87
Peptide-receptive class I major histocompatibility complex molecules on TAP-deficient and wild-type cells and their roles in the processing of exogenous antigens. Immunology (1999) 0.86
Macrophages present exogenous antigens by class I major histocompatibility complex molecules via a secretory pathway as a consequence of interferon-gamma activation. Immunology (2001) 0.85
Potential prospects of nanomedicine for targeted therapeutics in inflammatory bowel diseases. World J Gastroenterol (2012) 0.85
CD8(+) T-cell priming against a nonsecreted Listeria monocytogenes antigen is independent of the antimicrobial activities of gamma interferon. Infect Immun (2000) 0.83
An approach to the identification of T cell epitopes in the genomic era: application to Francisella tularensis. Immunol Res (2009) 0.82
The same well-characterized T cell epitope SIINFEKL expressed in the context of a cytoplasmic or secreted protein in BCG induces different CD8+ T cell responses. Immunol Lett (2009) 0.82
Salmonella modulates B cell biology to evade CD8(+) T cell-mediated immune responses. Front Immunol (2014) 0.81
Just-in-time vaccines: Biomineralized calcium phosphate core-immunogen shell nanoparticles induce long-lasting CD8(+) T cell responses in mice. Nanomedicine (2013) 0.81
Bacterial and host factors involved in the major histocompatibility complex class Ib-restricted presentation of Salmonella Hsp 60: novel pathway. Infect Immun (2004) 0.80
Tumor lysate-loaded biodegradable microparticles as cancer vaccines. Expert Rev Vaccines (2014) 0.79
Activation outcomes induced in naïve CD8 T-cells by macrophages primed via "phagocytic" and nonphagocytic pathways. Mol Biol Cell (2007) 0.79
Redirecting soluble antigen for MHC class I cross-presentation during phagocytosis. Eur J Immunol (2014) 0.79
The pathway of cross-presentation is influenced by the particle size of phagocytosed antigen. Immunology (2012) 0.79
Tumor vaccine against recurrence of hepatocellular carcinoma. World J Gastroenterol (2005) 0.78
An anti-nucleic acid antibody delivers antigen to the cross-presentation pathway in dendritic cells and potentiates therapeutic antitumor effects. J Immunol (2012) 0.77
Major histocompatibility complex class I presentation of exogenous and endogenous protein-derived peptides by a transfected human monocyte cell line. Immunology (1995) 0.77
Major histocompatibility complex class I peptide presentation after Salmonella enterica serovar typhimurium infection assessed via stable isotope tagging of the B27-presented peptide repertoire. Infect Immun (2004) 0.77
Evidence for Direct Inhibition of MHC-Restricted Antigen Processing by Dexamethasone. Immune Netw (2014) 0.76
Nanocarrier-based immunotherapy in cancer management and research. Immunotargets Ther (2014) 0.76
Metformin Suppresses MHC-Restricted Antigen Presentation by Inhibiting Co-Stimulatory Factors and MHC Molecules in APCs. Biomol Ther (Seoul) (2013) 0.75
Antigen presenting capacity of murine splenic myeloid cells. BMC Immunol (2017) 0.75
Peptide epitopes from noncytosolic Listeria monocytogenes can be presented by major histocompatibility complex class I molecules. Infect Immun (1996) 0.75
Construction and characterization of insect cell-derived influenza VLP: cell binding, fusion, and EGFP incorporation. J Biomed Biotechnol (2010) 0.75
Dually fluorescent core-shell microgels for ratiometric imaging in live antigen-presenting cells. PLoS One (2014) 0.75
Vanilloid Receptor 1 Agonists, Capsaicin and Resiniferatoxin, Enhance MHC Class I-restricted Viral Antigen Presentation in Virus-infected Dendritic Cells. Immune Netw (2016) 0.75
The forearm flap. Clin Plast Surg (1982) 1.90
Frequency dependence of EPR signal-to-noise. J Magn Reson (1999) 1.75
Patient outcomes for the chronically critically ill: special care unit versus intensive care unit. Nurs Res (1996) 1.61
Unidirectional valve patch for repair of cardiac septal defects with pulmonary hypertension. Ann Thorac Surg (1995) 1.58
Evaluation of novel human immunodeficiency virus type 1 Gag DNA vaccines for protein expression in mammalian cells and induction of immune responses. J Virol (1999) 1.43
Repair of fistulas-in-ano using fibrin adhesive: long-term follow-up. Dis Colon Rectum (2000) 1.36
The upper arm free flap. Clin Plast Surg (1982) 1.31
Sorafenib inhibits activation of human peripheral blood T cells by targeting LCK phosphorylation. Leukemia (2008) 1.30
Absolute EPR spin echo and noise intensities. J Magn Reson (1999) 1.24
A field evaluation of the effect of pulsed arc welding technique on reducing worker exposures. Appl Occup Environ Hyg (2001) 1.22
Phagosomes are fully competent antigen-processing organelles that mediate the formation of peptide:class II MHC complexes. J Immunol (1999) 1.17
Summary of the NIOSH guidelines for air sampling and analytical method development and evaluation. Analyst (1996) 1.15
Expression of multidrug resistance protein/GS-X pump and gamma-glutamylcysteine synthetase genes is regulated by oxidative stress. J Biol Chem (1998) 1.05
Novel dipeptide aldehydes are proteasome inhibitors and block the MHC-I antigen-processing pathway. J Immunol (1995) 1.02
Surface thiols of human lymphocytes and their changes after in vitro and in vivo activation. J Leukoc Biol (1996) 1.00
Apolipoprotein B-48 or its apolipoprotein B-100 equivalent mediates the binding of triglyceride-rich lipoproteins to their unique human monocyte-macrophage receptor. Arterioscler Thromb Vasc Biol (1998) 0.98
Adaptive hypersensitivity to estradiol: potential mechanism for secondary hormonal responses in breast cancer patients. J Steroid Biochem Mol Biol (2001) 0.97
Multi-drug resistant tuberculosis in Chuuk State Federated States of Micronesia, 2008-2009. Pac Health Dialog (2010) 0.93
Repair of chronic anorectal fistulae using commercial fibrin sealant. Arch Surg (2000) 0.92
Treatment of blepharoptosis. Direct transplantation of the frontalis muscle to the upper eyelid. Clin Plast Surg (1982) 0.90
Thermolabile H-2Kb molecules expressed by transporter associated with antigen processing-deficient RMA-S cells are occupied by low-affinity peptides. J Immunol (1999) 0.90
Some statistical procedures for analytical method accuracy tests and estimation. Am Ind Hyg Assoc J (1996) 0.90
A nuclear role for Kaposi's sarcoma-associated herpesvirus-encoded K13 protein in gene regulation. Oncogene (2008) 0.89
Interleukin-12 promotes enhanced resistance to Listeria monocytogenes infection of lead-exposed mice. Toxicol Appl Pharmacol (1997) 0.86
Cellular binding site and membrane binding proteins for triglyceride-rich lipoproteins in human monocyte-macrophages and THP-1 monocytic cells. J Lipid Res (1994) 0.86
Neuronal cell death and reactive oxygen species. Cell Mol Neurobiol (2000) 0.86
One-stage inferior labial flap and its pertinent anatomic study. Plast Reconstr Surg (1993) 0.85
The cost-effectiveness of a special care unit to care for the chronically critically ill. J Nurs Adm (1995) 0.85
Preparation of a cis-isoprostane synthon. J Org Chem (2000) 0.84
Quantitative evaluation of motor functional recovery process in chronic stroke patients during robot-assisted wrist training. J Electromyogr Kinesiol (2008) 0.84
A macrophage receptor for apolipoprotein B48: cloning, expression, and atherosclerosis. Proc Natl Acad Sci U S A (2000) 0.84
Processing of bacterial antigens for presentation to class I and II MHC-restricted T lymphocytes. Infect Agents Dis (1995) 0.83
A profile of the belief system and attitudes to end-of-life decisions of senior clinicians working in a National Health Service Hospital in the United Kingdom. Palliat Med (2008) 0.82
Corrective treatment of the Mandarin bound foot. Clin Plast Surg (1982) 0.82
Comparison of sampling methods for monomer and polyisocyanates of 1,6-hexamethylene diisocyanate during spray finishing operations. Appl Occup Environ Hyg (2000) 0.82
Coping of cancer patients during and after radiotherapy--a follow-up of 2 years. Onkologie (2003) 0.82
Phosphatidylinositol 3-kinase/Akt pathway mediates heme oxygenase-1 regulation by lipopolysaccharide. Cell Mol Biol (Noisy-le-grand) (2005) 0.81
Carnosine protects against excitotoxic cell death independently of effects on reactive oxygen species. Neuroscience (1999) 0.80
China's coastal population and economic development: summary of the symposium. Chin J Popul Sci (1992) 0.80
Upstream regions of the estrogen receptor alpha proximal promoter transcript regulate ER protein expression through a translational mechanism. Mol Cell Endocrinol (2005) 0.79
Simvastatin reduces OX40 and OX40 ligand expression in human peripheral blood mononuclear cells and in patients with atherosclerotic cerebral infarction. J Int Med Res (2009) 0.79
Overexpression of P-glycoprotein but not its mRNA in multidrug resistant cells selected with hydroxyrubicin. Anticancer Res (1995) 0.78
Sutural expansion osteogenesis for management of the bony-tissue defect in cleft palate repair: experimental studies in dogs. Plast Reconstr Surg (2000) 0.78
Do-not-resuscitate practices in the chronically critically ill. Heart Lung (1996) 0.78
Surgical treatment of lymphedema of the lower extremity. Clin Plast Surg (1982) 0.77
Antipeptide antibodies reveal interrelationships of MBP 200 and MBP 235: unique apoB-specific receptors for triglyceride-rich lipoproteins on human monocyte-macrophages. J Lipid Res (1999) 0.77
Anal reconstruction by a modified Pickrell procedure. Clin Plast Surg (1982) 0.77
A novel cis-acting element is involved in the promoter activity of the rat mdr1b gene. Cell Growth Differ (1996) 0.76
Regulation of multidrug resistance gene mdr1b/mdr1 expression in isolated mouse uterine epithelial cells. J Cell Physiol (1995) 0.76
Reconstruction of the cheek and lips. Clin Plast Surg (1982) 0.75
[A serial histological study on suture expansion osteogenesis for cleft palate closure]. Zhonghua Zheng Xing Wai Ke Za Zhi (2000) 0.75
Survival experience of chronically critically ill patients. Nurs Res (1996) 0.75
Specific cleavage of two target sequences of the tobacco mosaic virus RNA by a di-component ribozyme. Chin J Biotechnol (1995) 0.75
Experiences with the Krukenberg plastic operation. Clin Plast Surg (1982) 0.75
Study of boron neutron capture therapy used neutron source with protons bombarding a thick 9Be target. Med Phys (1997) 0.75
[Suture expansion osteogenesis for closing the posterior hard palate: an experimental study in dogs]. Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi (1999) 0.75
Repair of large mandibular defects with vascularized rib grafts. Clin Plast Surg (1982) 0.75
Breast volume measurement in 125 young Chinese women. Chin Med Sci J (1992) 0.75
The "extended" skin graft. Clin Plast Surg (1982) 0.75
[Applied anatomy of arterial supply for the soft palate]. Zhonghua Zheng Xing Wai Ke Za Zhi (2000) 0.75
The "uplift operation" for repair of cleft palate. Clin Plast Surg (1982) 0.75
Evaluation of a chemical spot-test kit for the detection of airborne particulate lead in the workplace. Am Ind Hyg Assoc J (1996) 0.75
[Hard palate lengthening by palatal suture expansion: an experimental study in dogs]. Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi (1999) 0.75
An experimental study of electro-acupuncture on auditory impairment caused by kanamycin in guinea pigs. J Tradit Chin Med (1999) 0.75
Reconstruction of the external ear. Clin Plast Surg (1982) 0.75
[Analysis on the dermal irritation caused by imported cosmetics]. Wei Sheng Yan Jiu (2001) 0.75
[Suture distraction osteogenesis for closure of cleft palate in the dog: long-term effect and its influence on facial growth]. Zhonghua Zheng Xing Wai Ke Za Zhi (2000) 0.75
[Effects of functional electrical stimulation based on normal gait pattern on walking function in subjects with recovery of stroke]. Zhonghua Yi Xue Za Zhi (2016) 0.75
[Tissue response in circum-maxillary sutures after transverse palated suture expansion]. Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi (1999) 0.75
Characteristics and causes of the fertility transition in China. Chin J Popul Sci (1993) 0.75
Coactivations of elbow and shoulder muscles in hemiplegic persons with chronic stroke during robot-assisted training. Conf Proc IEEE Eng Med Biol Soc (2006) 0.75
[Miniplate osteosynthesis for multiple mandibular fractures]. Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi (1997) 0.75
Hypospadias repair. Clin Plast Surg (1982) 0.75
Synthesis, characterization and antitumor activity of quinolone-platinum(II) conjugates. J Inorg Biochem (2001) 0.75
Ultrasonic extraction and portable anodic stripping voltammetric measurement of lead in paint, dust wipes, soil, and air: an interlaboratory evaluation. J Environ Monit (1999) 0.75
[Preventive and therapeutic effect of Chinese herbs naofeikang on experimental emphysema and pulmonary artery hypertension in hamsters]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao (2000) 0.75
[Treatment of ototoxic auditory damage caused by kanamycin with electroacupuncture at different acupoints]. Zhen Ci Yan Jiu (1995) 0.75
Interlaboratory and intralaboratory variabilities in the Environmental Lead Proficiency Analytical Testing (ELPAT) Program. Am Ind Hyg Assoc J (1997) 0.75
Reconstruction of the vagina with sensory function. Clin Plast Surg (1982) 0.75
A modified rat model of acute limb allograft rejection. Transplant Proc (2011) 0.75
The longitudinal cross-leg flap. Clin Plast Surg (1982) 0.75
Laboratory and analytical method performance of lead measurements in paint chips, soils, and dusts. Am Ind Hyg Assoc J (1996) 0.75
Community development and change of fertility rate: comments on the research concerning the investigation of the world's fertility rate. Chin J Popul Sci (1993) 0.75
Repair of unilateral cleft lip with the "inverted Tennison method". Clin Plast Surg (1982) 0.75
[Effects of selenium polysaccharide and sodium selenite on blood selenium concentration and liver cytochrome P450 monooxygenase system in rat]. Wei Sheng Yan Jiu (1998) 0.75
[The anatomic study of levator veli palatini muscle]. Zhonghua Kou Qiang Yi Xue Za Zhi (1995) 0.75
Corrections to the target and critical values for the National Institute for Occupational Safety and Health validation tests. Am Ind Hyg Assoc J (1996) 0.75
Risk projection and the fertility of rural families. Chin J Popul Sci (1991) 0.75
[Effect of herbs 814 on tumor necrosis factor a production from alveolar macrophages in vitro]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao (1998) 0.75
Physiological responses of Pinus sylvestris var. mongolica seedlings to the interaction between Suillus luteus and Trichoderma virens. Curr Microbiol (2014) 0.75
Repair of the unilateral congenital cleft palate. Clin Plast Surg (1982) 0.75
Breast reconstruction without a silicone implant. Clin Plast Surg (1982) 0.75
Total reconstruction of the male genitalia. Clin Plast Surg (1982) 0.75
One-stage reconstruction of the nose. The island frontal flap and the "conjoined" frontal flap. Clin Plast Surg (1982) 0.75